Evidence map›Paper›PMID 39903184›Full record

ArticleJournal of bacteriology2025

Robust and highly efficient transformation method for a minimal mycoplasma cell.

Masaki Mizutani, John I Glass, Takema Fukatsu, Yo Suzuki, Shigeyuki Kakizawa

Abstract read
In one paragraph

Article in Journal of bacteriology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Live imaging of bacterial actin MreBs fromBiophysics and physicobiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Masaki MizutaniBioproduction Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki Prefecture, Japan.ORCID 0000-0001-7950-4866
John I GlassSynthetic Biology Group, J. Craig Venter Institute, La Jolla, California, USA.
Takema FukatsuBioproduction Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki Prefecture, Japan.
Yo SuzukiSynthetic Biology Group, J. Craig Venter Institute, La Jolla, California, USA.
Shigeyuki KakizawaBioproduction Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki Prefecture, Japan.ORCID 0000-0003-3885-4434

Funding

Japan Agency for Medical Research and Development (AMED) JP23gm1610002MEXT | Japan Science and Technology Agency (JST) JPMJER1902MEXT | Japan Society for the Promotion of Science (JSPS) 18H02433, 26710015, 26106004, 15KK0266MEXT | Japan Society for the Promotion of Science (JSPS) 24K18102, 22KJ318MEXT | Japan Society for the Promotion of Science (JSPS) JP17H06388
6 · The paper itself

Abstract

Mycoplasmas have been widely investigated for their pathogenicity, as well as for genomics and synthetic biology. Conventionally, transformation of mycoplasmas was not highly efficient, and due to the low transformation efficiency, large amounts of DNA and recipient cells were required for that purpose. Here, we report a robust and highly efficient transformation method for the minimal cell JCVI-syn3B, which was created through streamlining the genome of IMPORTANCE: Mycoplasmas are parasitic and pathogenic bacteria for many animals. They are also useful bacteria to understand the cellular process of life and for bioengineering because of their simple metabolism, small genomes, and cultivability. Genetic manipulation is crucial for these purposes, but transformation efficiency in mycoplasmas is typically quite low. Here, we report a highly efficient transformation method for the minimal genome mycoplasma JCVI-syn3B. Using this method, transformants can be obtained with only 10 ng of plasmid DNA, which is around one-thousandth of the amount required for traditional mycoplasma transformations. Moreover, a convenient method using frozen stocks of transformation-ready cells was established. These improved methods play a crucial role in further studies using minimal cells.

Indexed as

MycoplasmaMycoplasma mycoidesTransformation, BacterialDNA, BacterialGenome, BacterialPlasmidsDNA, Bacterialgrowth curveMycoplasmatransformation

Identifiers

PMID39903184
PMCPMC11925241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.